These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3149682)

  • 1. The future streptococcal M. vaccine against rheumatic fever.
    Imran M; Jan A
    J Pak Med Assoc; 1988 Jul; 38(7):176-7. PubMed ID: 3149682
    [No Abstract]   [Full Text] [Related]  

  • 2. Changing streptococci and prospects for the global eradication of rheumatic fever.
    Stollerman GH
    Perspect Biol Med; 1997; 40(2):165-89. PubMed ID: 9058950
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccine strategies to prevent rheumatic fever.
    Brandt ER; Good MF
    Immunol Res; 1999; 19(1):89-103. PubMed ID: 10374697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing epidemiology of acute rheumatic fever in the United States.
    Lee GM; Wessels MR
    Clin Infect Dis; 2006 Feb; 42(4):448-50. PubMed ID: 16421786
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary prevention of rheumatism: the status and outlook (vaccine)].
    Rotta Y
    Ter Arkh; 1985; 57(11):97-100. PubMed ID: 3909476
    [No Abstract]   [Full Text] [Related]  

  • 6. Streptococcal M protein.
    Fischetti VA
    Sci Am; 1991 Jun; 264(6):58-65. PubMed ID: 1857955
    [No Abstract]   [Full Text] [Related]  

  • 7. Group A streptococcus vaccine may be ready for phase I clinical trials in late 1989.
    Raymond CA
    JAMA; 1988 Nov; 260(19):2778. PubMed ID: 3054182
    [No Abstract]   [Full Text] [Related]  

  • 8. Decline in rheumatic fever.
    Lancet; 1985 Sep; 2(8456):647-8. PubMed ID: 2863636
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of group a streptococcal anti-M type-specific antibody in sera of rheumatic fever patients after 45 years.
    Bencivenga JF; Johnson DR; Kaplan EL
    Clin Infect Dis; 2009 Oct; 49(8):1237-9. PubMed ID: 19761409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatic fever.
    Stollerman GH
    Lancet; 1997 Mar; 349(9056):935-42. PubMed ID: 9093263
    [No Abstract]   [Full Text] [Related]  

  • 11. The changing face of rheumatic fever in the 20th century.
    Stollerman GH
    J Med Microbiol; 1998 Aug; 47(8):655-7. PubMed ID: 9877185
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci.
    Pruksakorn S; Currie B; Brandt E; Martin D; Galbraith A; Phornphutkul C; Hunsakunachai S; Manmontri A; Good MF
    Lancet; 1994 Sep; 344(8923):639-42. PubMed ID: 7520963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for a group A streptococcal vaccine.
    McMillan DJ; Chhatwal GS
    Curr Opin Mol Ther; 2005 Feb; 7(1):11-6. PubMed ID: 15732524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type-specific antibodies to purified streptococcal M proteins from potentially rheumatogenic M-types in patients with rheumatic fever and rheumatic heart disease.
    Thakur A; Singhal S; Prakash K
    J Med Microbiol; 1996 Dec; 45(6):483-9. PubMed ID: 8958254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    Trans Assoc Am Physicians; 1988; 101():88-92. PubMed ID: 3077732
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-reactivity between streptococcus and human tissue: a model of molecular mimicry and autoimmunity.
    Froude J; Gibofsky A; Buskirk DR; Khanna A; Zabriskie JB
    Curr Top Microbiol Immunol; 1989; 145():5-26. PubMed ID: 2680297
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenesis of rheumatic fever: a review.
    Rotta J
    Ann Trop Paediatr; 1983 Mar; 3(1):1-8. PubMed ID: 6191642
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigenic epitope mapping of the M24 protein of Streptococcus pyogenes: implications for serodiagnosis of rheumatic fever.
    Norton RE; Heuzenroeder M; Manning PA
    FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):267-71. PubMed ID: 9116645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group A streptococcal antigens and vaccine potential.
    Kehoe MA
    Vaccine; 1991 Nov; 9(11):797-806. PubMed ID: 1722063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against streptococcal pharyngeal colonization with vaccines composed of M protein conserved regions.
    Fischetti VA; Bessen DE; Schneewind O; Hruby DE
    Adv Exp Med Biol; 1991; 303():159-67. PubMed ID: 1805563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.